Clinical Trial

Lattice Radiotherapy for Adults With Large Tumors

Study acronym: LRT
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to ask whether using a specialized radiation therapy technique called Lattice Radiation Therapy (LRT) can shrink large tumors when given with palliative radiation therapy. The primary questions are: * if LRT is safe and does not worsen existing side effects or cause new side effects * if adding LRT to standard radiation therapy can improve tumor shrinkage. Participants will have one additional radiation treatment (LRT) prior to starting palliative radiation and then their progress will be followed for one year.
Protocol Amendment History 1 change
critical Primary endpoint(s) modified 2026-07-02
Trial Details
NCT Number NCT07647679
Lead Sponsor Duke University
Conditions Large Tumor, Palliative Radiotherapy
Enrollment 25 participants
Start Date 2026-08-01
Primary Completion 2029-11 (estimated)
Study Completion 2030-08 (estimated)
Updated on ClinicalTrials.gov 2026-07-01